| Year |
Citation |
Score |
| 2013 |
Hadimani MB, Macdonough MT, Ghatak A, Strecker TE, Lopez R, Sriram M, Nguyen BL, Hall JJ, Kessler RJ, Shirali AR, Liu L, Garner CM, Pettit GR, Hamel E, Chaplin DJ, et al. Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent. Journal of Natural Products. 76: 1668-78. PMID 24016002 DOI: 10.1021/Np400374W |
0.597 |
|
| 2009 |
Shirali A, Sriram M, Hall JJ, Nguyen BL, Guddneppanavar R, Hadimani MB, Ackley JF, Siles R, Jelinek CJ, Arthasery P, Brown RC, Murrell VL, McMordie A, Sharma S, Chaplin DJ, et al. Development of synthetic methodology suitable for the radiosynthesis of combretastatin A-1 (CA1) and its corresponding prodrug CA1P. Journal of Natural Products. 72: 414-21. PMID 19161336 DOI: 10.1021/Np800661R |
0.405 |
|
| 2002 |
Hadimani MB, Kessler RJ, Kautz JA, Ghatak A, Shirali AR, O'Dell H, Garner CM, Pinney KG. 2-(3-tert-Butyldimethylsiloxy-4-methoxyphenyl)-6-methoxy-3-(3,4,5-trimethoxybenzoyl)indole. Acta Crystallographica. Section C, Crystal Structure Communications. 58: o330-2. PMID 12050432 DOI: 10.1107/S0108270102003669 |
0.698 |
|
| 2002 |
Hadimani MB, Kessler RJ, Kautz JA, Ghatak A, Shirali AR, O'Dell H, Garner CM, Pinney KG. 2-(3-tert-butyldimethylsiloxy-4-methoxyphenyl)-6-methoxy-3-(3,4, 5-trimethoxybenzoyl)indole Acta Crystallographica Section C: Crystal Structure Communications. 58: o330-o332. DOI: 10.1107/S0108270102003669 |
0.742 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Nabulsi NB, Holden D, Zheng MQ, Bois F, Lin SF, Najafzadeh S, Gao H, Ropchan J, Lara-Jaime T, Labaree D, Shirali A, Slieker LJ, Jesudason CD, Barth VN, Navarro A, et al. Evaluation of C-LSN3172176 as a novel PET tracer for imaging M muscarinic acetylcholine receptors in non-human primates. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30733324 DOI: 10.2967/jnumed.118.222034 |
0.243 |
|
| 2019 |
Li S, Zheng M, Naganawa M, Gao H, Pracitto R, Shirali A, Lin SF, Teng JK, Ropchan J, Huang Y. Novel kappa opioid receptor agonist as improved PET radiotracer: Development and in vivo evaluation. Molecular Pharmaceutics. PMID 30726092 DOI: 10.1021/acs.molpharmaceut.8b01209 |
0.183 |
|
| 2019 |
Gallezot JD, Nabulsi NB, Henry S, Pracitto R, Planeta B, Ropchan J, Lin SF, Labaree D, Kapinos M, Shirali A, Lara-Jaime T, Gao H, Matuskey D, Walzer M, Marek G, et al. IMAGING THE ENZYME 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 WITH POSITRON EMISSION TOMOGRAPHY: EVALUATION OF THE NOVEL RADIOTRACER C-AS2471907 IN HUMAN BRAIN. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30877174 DOI: 10.2967/Jnumed.118.219766 |
0.181 |
|
| 2017 |
Lin SF, Bois F, Holden D, Nabulsi N, Pracitto R, Gao H, Kapinos M, Teng JK, Shirali A, Ropchan J, Carson RE, Elmore CS, Vasdev N, Huang Y. The Search for a Subtype-Selective PET Imaging Agent for the GABAA Receptor Complex: Evaluation of the Radiotracer [(11)C]ADO in Nonhuman Primates. Molecular Imaging. 16: 1536012117731258. PMID 28929924 DOI: 10.1177/1536012117731258 |
0.167 |
|
| 2016 |
Cai Z, Li SY, Pracitto R, Navarro A, Shirali A, Ropchan J, Huang YH. A Fluorine-18-labeled Antagonist for PET Imaging of Kappa Opioid Receptors. Acs Chemical Neuroscience. PMID 27741398 DOI: 10.1021/Acschemneuro.6B00268 |
0.133 |
|
| 2019 |
Li S, Cai Z, Zhang W, Holden D, Lin SF, Finnema SJ, Shirali A, Ropchan J, Carre S, Mercier J, Carson RE, Nabulsi N, Huang Y. Synthesis and in vivo evaluation of [F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A). European Journal of Nuclear Medicine and Molecular Imaging. PMID 31175396 DOI: 10.1007/S00259-019-04357-W |
0.116 |
|
| 2022 |
Chen X, Cuffari BJ, Dubljevic V, Shirali A, Zhou J, Campbell JA, Suits SC, O'Sullivan KM, Hansen JE. Inhibition of NETosis by a Nuclear-Penetrating Anti-DNA Autoantibody. Immunohorizons. 6: 356-365. PMID 35697479 DOI: 10.4049/immunohorizons.2100091 |
0.103 |
|
| 2019 |
Bini J, Sanchez-Rangel E, Gallezot JD, Naganawa M, Nabulsi NB, Lim K, Nahafzadeh S, Shirali A, Ropchan J, Matuskey D, Huang H, Herold K, Harris PE, Sherwin RS, Carson RE, et al. PET Imaging of Pancreatic Dopamine D3/D2 receptor density with C (+)-PHNO in Type-1 Diabetes Mellitus. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31601695 DOI: 10.2967/Jnumed.119.234013 |
0.103 |
|
| 2021 |
Rattray Z, Deng G, Zhang S, Shirali A, May CK, Chen X, Cuffari BJ, Liu J, Zou P, Rattray NJ, Johnson CH, Dubljevic V, Campbell JA, Huttner A, Baehring JM, et al. ENT2 facilitates brain endothelial cell penetration and blood-brain barrier transport by a tumor-targeting anti-DNA autoantibody. Jci Insight. PMID 34128837 DOI: 10.1172/jci.insight.145875 |
0.087 |
|
| 2020 |
Jia H, Cai Z, Holden D, He Y, Lin SF, Li S, Baum E, Shirali A, Kapinos M, Gao H, Ropchan J, Huang Y. Positron Emission Tomography Imaging Evaluation of a Novel 18F-Labeled Sigma-1 Receptor Radioligand in Cynomolgus Monkeys. Acs Chemical Neuroscience. PMID 32356969 DOI: 10.1021/Acschemneuro.0C00171 |
0.077 |
|
| 2020 |
Cai Z, Li S, Zhang W, Pracitto R, Wu X, Baum E, Finnema SJ, Holden D, Toyonaga T, Lin SF, Lindemann M, Shirali A, Labaree DC, Ropchan J, Nabulsi N, et al. Synthesis and Preclinical Evaluation of an 18F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [18F]SynVesT-2. Acs Chemical Neuroscience. PMID 31961649 DOI: 10.1021/Acschemneuro.9B00618 |
0.074 |
|
| Hide low-probability matches. |